PGNY - Company ID 0001551306
The table below shows Progyny, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.29B | $1.17B | $1.09B | $786.91M | $500.62M | $344.86M |
| Cost of revenue | $984.18M | $913.86M | $849.80M | $619.59M | $388.49M | $274.80M |
| Gross profit | $304.48M | $253.36M | $238.80M | $167.32M | $112.14M | $70.06M |
| R&D | $9.50M | - | - | - | - | - |
Progyny, Inc. reported annual revenue of $1.29B for fiscal year 2025. That is up 10.4% from $1.17B in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $48.58M (FY 2017) to $1.29B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $147.09M |
| $121.96M |
| $117.13M |
| $98.33M |
| $59.62M |
| $46.70M |
| Operating income | $85.28M | $67.45M | $62.18M | $23.34M | $32.34M | $8.35M |
| Income tax | $36.91M | $28.87M | $8.65M | -$5.92M | -$33.33M | -$37.78M |
| Net income | $58.52M | $54.34M | $62.04M | $30.36M | $65.77M | $46.46M |
| EPS (diluted) | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 | $0.47 |